Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rangering i aksjer #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aksjekurs
$0.0202
Sist synkronisert: 2024-11-19
Markedsverdi
$44.67K
Endring (1 dag)
-0.49%
Endring (1 år)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Kategori

EPS for Notable Labs, Ltd. (NTBL)
EPS per June 2024 TTM: $-0.97
Ifølge de siste økonomiske rapportene og aksjekursen til Notable Labs, Ltd. er selskapets nåværende EPS (TTM) $-0.97. Ved slutten av 2022 hadde selskapet en EPS på $-6.50, en økning sammenlignet med EPS-en i 2021 som var $-0.22.
EPS-historikk for Notable Labs, Ltd. fra 2015 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.97 -80.72%
2023 $-5.03 -22.62%
2022 $-6.50 2,854.55%
2021 $-0.22 -54.17%
2020 $-0.48 26.32%
2019 $-0.38 -38.71%
2018 $-0.62 67.57%
2017 $-0.37 -42.19%
2016 $-0.64 -12.33%
2015 $-0.73 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -1,885.57%
US
$27.74 -2,959.79%
NL
- -
CH
- -
KR
$13.70 -1,512.38%
BE